Cite
HARVARD Citation
Wu, Y. et al. (2021). Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost‐savings. Internal medicine journal. 51 (5), pp. 739-745. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wu, Y. et al. (2021). Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost‐savings. Internal medicine journal. 51 (5), pp. 739-745. [Online].